FDA Clears Kent Imaging’s Multispectral Medical Imaging Device (KD203)

October 19, 2017 |

1 min read

TESARO Announces U.S. FDA Approval of VARUBI IV fo

Kent’s device is the next step in perfusion imaging by directly showing tissue oxygenation.

Kent Imaging Revolutionizes Perfusion Imaging with Their FDA Cleared KD203

[19-October-2017]

CALGARY, Oct. 19, 2017 /PRNewswire/ - Kent Imaging, a leading provider of near infrared imaging solutions, announced today that the U.S. Food and Drug Administration (FDA) has cleared their multispectral Medical Imaging Device (KD203).

Kent’s device is the next step in perfusion imaging by directly showing tissue oxygenation. The KD203 provides insight into the availability of oxygenated blood in tissue, which enables accurate diagnosis, improved treatment planning and effective patient monitoring.

“Using the Kent camera, we can quantify perfusion directly by determining the ratio of oxygenated to deoxygenated hemoglobin”, said Dr. Adam Landsman, DPM, PhD, Chief of Division of Podiatric Surgery at the Cambridge Health Alliance (Harvard Medical School). “Furthermore, because the data can be collected in less than a second, the device can help to quantify the effect of our treatments, and allow us to easily monitor the patient’s condition on a regular basis.”

“We are very excited about obtaining Class II FDA clearance for our handheld device”, said Pierre Lemire, CEO of Kent Imaging. “Our low cost and easy to use device helps physicians to determine the most effective treatment plans which provides them a means of reducing recovery times and patient discomfort.”

Features of Kent’s KD203:

Instant wound assessment
Non-invasive with no injectables or dyes
A means to track patient progress and treatment effectiveness
Provides quantified tissue oxygenation levels
No disruption to existing workflow
Accurate, unlimited imaging and storage
Ease-of-use with minimal training required
Low cost device with no disposables
Lightweight portable handheld device

The KD203 is now available for sale in both the United States and Canada.

About Kent Imaging Inc.

Kent Imaging, located in Calgary, Alberta, Canada, is a leading developer of medical technology, who designs, manufactures and markets imaging technology for wound and surgical care. Kent holds multiple patents in medical technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. For more information about our company visit us at www.kentimaging.com.

SOURCE Kent Imaging Inc.

FDA Approvals Medtech Medical device